This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Hansjoerg Lehmann
Introduction
Hansjoerg Lehmann is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative chemical structures and their therapeutic applications.
Latest Patents
Hansjoerg Lehmann holds a patent for "Substituted quinazolin-4-one derivatives." This patent includes substituted quinazolin-4-one compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof. These compounds are designed to treat disorders or diseases mediated by the activity of class I PI3K kinases. His innovative approach in this area has the potential to impact various therapeutic strategies.
Career Highlights
Lehmann is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research. His patent portfolio reflects his commitment to advancing medical science through innovative solutions.
Collaborations
Some of his notable coworkers include Zhenxing Du and Samuel Hintermann. Their collaborative efforts have further enhanced the research and development initiatives at Novartis AG.
Conclusion
Hansjoerg Lehmann's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile